UTSI [UTSTARCOMS] SC TO-C: (Original Filing)

[SCHEDULE TO (RULE 13e-4) TENDER OFFER STATEMENT UNDER UTStarcom Holdings Corp. (Name of Subject Company (Issuer)) UTStarcom Holdings Corp. (Name of Filing Persons (Issuer and Offeror)) Ordinary Shares, $0.00125 par value (Title of Class of Securities) G9310A106 (CUSIP Number of Class of Securities) William Wong Daxing District, Beijing, P.R. China (86 10) 8520-5588 With a copy to: Scott Anthony CALCULATION] [UTStarcom Announces Plans for a Cash Tender Offer for up to US$30 Million of its Outstanding Ordinary Shares and Plans for a Reverse Share Split BEIJING, November 19, 2012 — UTStarcom Holdings Corp. (“UTStarcom” or the “Company”), a leading provider of media operational support services and broadband equipment products and services, today announced two significant actions to enhance liquidity. The]

By | 2016-03-01T11:48:06+00:00 November 19th, 2012|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] SC TO-C: SCHEDULE TO (RULE 13e-4) TENDER OFFER STATEMENT UNDER

[SCHEDULE TO (RULE 13e-4) TENDER OFFER STATEMENT UNDER UTStarcom Holdings Corp. (Name of Subject Company (Issuer)) UTStarcom Holdings Corp. (Name of Filing Persons (Issuer and Offeror)) Ordinary Shares, $0.00125 par value (Title of Class of Securities) G9310A106 (CUSIP Number of Class of Securities) William Wong Daxing District, Beijing, P.R. China (86 10) 8520-5588 With a copy to: Scott Anthony CALCULATION] [UTStarcom Announces Plans for a Cash Tender Offer for up to US$30 Million of its Outstanding Ordinary Shares and Plans for a Reverse Share Split BEIJING, November 19, 2012 — UTStarcom Holdings Corp. (“UTStarcom” or the “Company”), a leading provider of media operational support services and broadband equipment products and services, today announced two significant actions to enhance liquidity. The]

By | 2016-03-01T11:49:29+00:00 November 19th, 2012|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 6-K: (Original Filing)

[UTStarcom Announces Plans for a Cash Tender Offer for up to US$30 Million of its Outstanding Ordinary Shares and Plans for a Reverse Share Split BEIJING, November 19, 2012 — UTStarcom Holdings Corp. (“UTStarcom” or the “Company”), a leading provider of media operational support services and broadband equipment products and services, today announced two significant actions to enhance liquidity. The]

By | 2016-03-01T11:50:56+00:00 November 19th, 2012|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 6-K: UTStarcom Announces Plans for a Cash Tender Offer

[UTStarcom Announces Plans for a Cash Tender Offer for up to US$30 Million of its Outstanding Ordinary Shares and Plans for a Reverse Share Split BEIJING, November 19, 2012 — UTStarcom Holdings Corp. (“UTStarcom” or the “Company”), a leading provider of media operational support services and broadband equipment products and services, today announced two significant actions to enhance liquidity. The]

By | 2016-03-01T11:51:51+00:00 November 19th, 2012|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By | 2016-03-03T11:36:08+00:00 November 19th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 5 EX-32.2]

By | 2016-02-07T15:34:54+00:00 November 19th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

UMC [UNITED MICROELECTRONICS] 6-K: (Original Filing)

[Description 99.1 Announcement on 2012/10/30: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2012/10/31: UMC announced its unconsolidated operating results for the third quarter of 2012 99.3 Announcement on 2012/10/31: To announce related materials on disposal of common shares of PARADE TECHNOLOGIES LTD. on behalf of UMC Capital Corporation 99.4 Announcement on 2012/11/07: To announce] [FORM 6-K November 19, 2012 United Microelectronics Corporation ——————————————————————————————————— No. 3 Li Hsin Road II ——————————————————————————————————— x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 11/19/2012 6-K 1 htm_7197.htm LIVE FILING]

By | 2016-03-23T16:23:51+00:00 November 19th, 2012|Categories: Chinese Stocks, SEC Original, UMC|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2012

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 5 EX-32.2]

By | 2016-02-07T15:35:48+00:00 November 19th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

UMC [UNITED MICROELECTRONICS] 6-K: Description 99.1 Announcement on 2012/10/30: To announce related

[Description 99.1 Announcement on 2012/10/30: To announce related materials on acquisition of machinery and equipment 99.2 Announcement on 2012/10/31: UMC announced its unconsolidated operating results for the third quarter of 2012 99.3 Announcement on 2012/10/31: To announce related materials on disposal of common shares of PARADE TECHNOLOGIES LTD. on behalf of UMC Capital Corporation 99.4 Announcement on 2012/11/07: To announce] [FORM 6-K November 19, 2012 United Microelectronics Corporation ——————————————————————————————————— No. 3 Li Hsin Road II ——————————————————————————————————— x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 11/19/2012 6-K 1 htm_7197.htm LIVE FILING]

By | 2016-03-23T16:25:24+00:00 November 19th, 2012|Categories: Chinese Stocks, UMC, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEF 14A: SCHEDULE 14A INFORMATION o Check the appropriate box:

[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, . Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]

By | 2016-02-07T21:52:28+00:00 November 19th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar